Tag: life science
Company News: LSP launches IPO of LSP Life Sciences Fund on NYSE Euronext
Having built an exceptional track record as one of Europe´s most successful and reputable investment firms in life sciences, LSP Life Sciences Partners has decided to set up a public fund, which has been taken public on NYSE Euronext today. The LSP Life Sciences Fund (ISIN: NL0009756394) is managed by Mark Wegter, Joep Muijrers and Geraldine O’Keeffe, all of which are seasoned investment professionals in the healthcare sector and have been responsible for LSP´s investments in public companies since 2008. Since then, the team has significantly outperformed the market and generated a return in excess of +150%, according to Mark Wegter.
The new fund takes a long-only investment strategy and allows generalist and retail investors to benefit from LSP´s outstanding expertise in life sciences – a highly complex and knowledge-driven sector. While investing primarily in Europe, there will also be selected U.S. investments. The fund´s goal is to participate in all forms of primary or secondary offerings, including follow-on offerings, block trades and IPOs – given that the respective investee company passes the team´s strict, comprehensive diligence process, which is regarded as a key to success by LSP.